Turning Point Brands Q2: 23% Revenue Jump, but 50% EBITDA Drop Makes the Stock Call Tricky

Revenue beat, profit squeeze: what Q2 really showed

This quarter came down to a straightforward question: is Turning Point Brands creating genuine demand, or merely paying for it? The evidence points to real demand, but the income statement is absorbing the cost. Revenue of $142.96 million beat the $122.48 million forecast, while adjusted EPS of $0.23 only narrowly missed the $0.25 consensus. In other words, customers and retailers wanted more product, but management is spending aggressively to sustain that momentum. With shares around $79.97 and well below the 52-week high of $146.90, investors do not appear to be paying a growth-stock premium. They are waiting to see whether this spending cycle eventually improves economics or simply makes the business more expensive to run.

The verdict so far

This looks more like a timing quarter than a broken one. The profit squeeze appears tied to investment, not to weak product demand. Management said the quarter included strategic sales and marketing investments linked to retail distribution, commercial capabilities, and brand development. Bulls will argue that is the right kind of expense if it secures shelf space and long-term loyalty. Bears will argue growth is getting expensive before margins have time to recover. The product story looks credible; the next question is whether those investments begin to leverage better in coming quarters.

Modern Oral is driving demand, while other categories lag

The revenue beat already suggested customers were showing up. The next test is whether that demand is concentrating in the products people actually buy.

Does the product mix pass the smell test?

Mostly yes. Modern Oral gross revenue increased 149% to $87.0 million, while net sales increased 128% to $68.4 million. More importantly, the segment now accounts for 48% of total company net sales, up from 26% of total revenue a year earlier. That is the kind of mix shift a business makes when one product line moves from niche to core. If shoppers keep choosing FRE and ALP, the sales base becomes more durable.

The rest of the portfolio is less exciting. Stoker's segment net sales rose 54.5%, but the broader context still points to Modern Oral as the main engine. Zig-Zag segment net sales fell 24.8%, which gives bears room to argue that legacy businesses are still drifting. For this stock, though, the key question is not whether every brand is firing. It is whether one meaningful consumer win can carry the company forward. Right now, the evidence suggests it can.

Are the economics holding up, or is accounting masking the squeeze?

Investors should keep this simple. Reported gross profit increased 40.6% to $93.7 million, but that included a tariff refund. Adjusting for that item, gross profit was $81.5 million. Even so, the margin profile still looks workable rather than damaged. That matters because one-off accounting can only hide pressure for so long. Over time, product strength and brand loyalty usually show up in margins. Here, the trace is still there.

Management also raised full-year 2026 Modern Oral gross and net sales guidance. Investors are now looking for proof that confidence is coming from stronger consumer demand, not just more expensive promotion.

The bull case rests on scale; the bear case rests on spending

The product demand appears real. The disagreement is about whether the income statement can keep pace.

The split is in the numbers

Bulls look at Modern Oral net sales increased 128% and argue the business is still early. Bears look at net income, which decreased 75.2% to $3.6 million, and adjusted EBITDA, which decreased 50.0% to $15.2 million, and argue the company is spending too fast.

That tension matters because management did not ask investors to ignore the cost of growth. It lifted Modern Oral sales guidance while keeping full-year adjusted EBITDA guidance unchanged at $70 million to $90 million. In plain English: management sees strong demand, but not yet the kind of operating leverage that lowers the cost of that growth.

Where the debate actually sits

Bull case - Modern Oral net sales increased 128% to $68.4 million, so the growth engine is real, not theoretical. - Management says spending is focused on retail distribution, commercial capabilities, and brand development, which could pay off if demand still exceeds shelf presence. - If that is correct, today's lower profits are the price of getting in early on a category shift.

Bear case - The profit picture has weakened materially, with adjusted EBITDA cut in half, so the spending is more than cosmetic. - Holding the $70 million to $90 million full-year adjusted EBITDA target after this quarter suggests the recovery window may be longer than bulls want. - If the spending is mainly defending against competition rather than creating durable new demand, margin pressure can persist.

What would confirm or challenge the story next quarter

The product appears to be working. Now investors need evidence that the business model is catching up.

Next quarter's scorecard

What would confirm the story - Sales keep growing without looking like a promotional binge. Management is already leaning on stronger consumer adoption and expanding market access, so the next quarter should show that traction is carrying more of the load. - The spending starts to look less open-ended. The company said investment was focused on retail distribution, commercial capabilities, and brand development. If those efforts are working, investors should see better cost leverage, not just larger spending. - Management still has room to breathe. With $268 million in cash after raising $60 million in equity, this is not an immediate financing story. That gives the company time to prove the model.

What would break it - The sales mix stops improving, or the company keeps needing heavier promotion to move product. - The income statement drifts so far from the $70 million to $90 million full-year adjusted EBITDA guide that investors lose confidence in the target. - Management keeps spending, but the business does not become simpler, cleaner, or more repeatable.

Keep it simple: if distribution and brand spending begin to produce steadier economics, this stock becomes easier to own. If not, the market may stop giving it time.